Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Harbin Medical University Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer headquartered in Meihekou, Jilin Province, China. The company specializes in the development and production of both chemical pharmaceuticals and Traditional Chinese Medicine (TCM) products. Its diverse portfolio addresses several major therapeutic areas, including cardiovascular health, gastroenterology, and hepatology. Key commercial products include Nao'an Granules for cerebrovascular health and Weikangling Capsules for gastric conditions. The company maintains state-of-the-art manufacturing facilities that comply with national GMP standards to ensure high-quality production for the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Harbin Medical University Pharmaceutical.